← Leaderboards
Susan Bullman
Dana-Farber Cancer Inst
$2,443,832
Attributed
$2,792,713
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,792,713 · 4
By mechanism
R01$1,945,443 · 2
R00$718,307 · 1
K99$128,963 · 1
Top collaborators
- Christopher D Johnston1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Wendy S. Garrett$9,434,998
- Shuji Ogino$10,631,973
- Laurie H Glimcher$56,303,115
- Ryan Lewis Collins$576,455
- Ramesh A Shivdasani$32,986,881
Others in their field
Other Emerging Leaders on “Bacteria”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Gary Fanger · Rise Therapeutics, Llc$19,697,313
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$14,299,891
Research focus
BacteriaCancer CellColorectal CancerInsightMicrobiotaFusobacterium NucleatumTissuesIn VivoTumorMalignant Neoplasm Of Gastrointestinal TractMalignant NeoplasmsMicrobeAnimal ModelCancer TherapyColorectal NeoplasmsNovel TherapeuticsMicrobialMicrobiomeMemberCancer ModelImmunotherapyCohortGenomicsIn Vitro
Grant awards (8)
Deciphering the Critical Determinants of Enteric and Tumor Niche Colonization by Microbes in Colorectal Cancer$697,763
R01 · FY2025 · CA
Defining the landscape of bacterial-colonized microniches in tumors and their role in intratumoral heterogeneity.$620,787
R01 · FY2025 · CA · contact PI
Defining the landscape of bacterial-colonized microniches in tumors and their role in intratumoral heterogeneity.$626,893
R01 · FY2024 · CA · contact PI
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy$204,273
R00 · FY2021 · CA · contact PI
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy$44,727
R00 · FY2021 · CA · contact PI
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy$220,307
R00 · FY2020 · CA · contact PI
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy$249,000
R00 · FY2019 · CA · contact PI
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy$128,963
K99 · FY2018 · CA · contact PI